1. Home
  2. Courses
Skip to main content
eLearning on BoehringerOne
newbanner_img

Diabetes

Learn the current best practice on type 2 diabetes.

 

PC-PH-104321 | Production Date: October 2023

Empagliflozin (JARDIANCE) as a Heart Failure Therapy

Empagliflozin (JARDIANCE) as a Heart Failure Therapy

Empagliflozin Heart Failure: EMPEROR-Reduced and Preserved Studies

Empagliflozin Heart Failure: EMPEROR-Reduced and Preserved Studies

Delivering 10 years of Improvements in Diabetes Care

Delivering 10 years of Improvements in Diabetes Care

The Discipline of Unified CRM Management in T2D: Improving Patients Outcomes through SGLT2i

The Discipline of Unified CRM Management in T2D: Improving Patients Outcomes through SGLT2i

The Future of T2D: A Holistic Approach in T2D Management with SGLT2i + DPP4i FDC

The Future of T2D: A Holistic Approach in T2D Management with SGLT2i + DPP4i FDC

Breaking Down the Evidence: Empagliflozin’s Role in Improving Glucose Control and CV Outcomes in T2D Patients

Breaking Down the Evidence: Empagliflozin’s Role in Improving Glucose Control and CV Outcomes in T2D Patients